- Case report
- Open Access
Combined 22q11.1-q11.21 deletion with 15q11.2-q13.3 duplication identified by array-CGH in a 6 years old boy
Molecular Cytogenetics volume 4, Article number: 6 (2011)
Deletions of chromosome 22q11 are present in over 90% of cases of DiGeorge or Velo-Cardio-Facial syndrome (DGS/VCFS). 15q11-q13 duplication is another recognized syndrome due to rearrangements of several genes, belonging to the category of imprinted genes. The phenotype of this syndrome varies but has been clearly associated with developmental delay and autistic spectrum disorders. Co-existence of the two syndromes has not been reported so far.
Here we report a 6-year-old boy presenting growth retardation, dysmorphic features and who exhibited learning difficulties. Fluorescence in situ hybridization (FISH) analysis of the proband revealed a deletion of DiGeorge Syndrome critical region (TUPLE). Array-CGH analysis revealed an interstitial duplication of 12 Mb in size in the area 15q11.2-q13.3, combined with a 3.2 Mb deletion at region 22q11.1-q11.21. FISH analysis in the mother showed a cryptic balanced translocation between chromosome 15 and chromosome 22 (not evident by classic karyotyping).
The clinical manifestations could be related to both syndromes and the importance of array-CGH analysis in cases of unexplained developmental delay is emphasized. The present case further demonstrates how molecular cytogenetic techniques applied in the parents were necessary for the genetic counseling of the family.
DiGeorge syndrome and Velo-Cardio-Facial syndrome (DGS/VCFS) are the result of deletions of chromosome 22q11.2 in over 90% of cases . The cardinal features and symptoms are cellular immunodeficiency due to thymus hypo or aplasia, hypocalcemia because of absence of the parathyroid, congenital heart defect with high mortality and morbidity, and typical faces . The prevalence of the syndrome is estimated (probably underestimated) to approximately 1:4,500 and represents one of the commonest genetic diseases .
The 4 Mb 15q11-q13 region, containing three biallelically expressed genes, which encode receptor subunits for the inhibitory neurotransmitter gamma-aminobutyric acid (GABRB3, GABRA5 and GABRG3), is prone to structural rearrangements [4, 5]. Duplications of this region occurring on the maternal chromosome, have been associated with a complex neurobehavioral phenotype that often includes language delay, seizures and autism (OMIM# 608636) [6–11, 4].
Clayton-Smith et al (1993) had initially reported a patient with a 15q11-q13 duplication including the Angelman syndrome critical region (ASCR), who had ataxia and moderate developmental delay, particularly of language, but neither epilepsy nor behavioural problems . Subsequently, Bundey et al (1994) reported a boy with mental retardation, infantile autism, ataxia, and seizures, who had a more extensive interstitial duplication of 15q11-q13, including the critical regions for Prader Willi syndrome (PWS) and AS on the maternally derived chromosome . Since then, various similar cases have been published and according to the literature duplications of the 15q11-q13 region constitute the most frequently reported chromosomal aberration in individuals with Autism Spectrum Disorders (ASDs) . Recently, our team reported the largest contiguous de novo interstitial duplication (15q11.2-q14) of the PWS/AS region (17.7 Mb) of maternal origin . The study though by Szafranski et al (2010) of a cohort of patients with small duplications (<1.6 Mb) at 15q13.2-q13.3 involving the CHRNA7 gene suggested association with developmental delay, mental retardation, muscular hypotonia and various neuropsychiatric disorders but did not prove clinical significance .
The use of array-CGH has increased the resolution available to studies of chromosomal abnormalities, from ≥ 5 Mb, achieved by metaphase Fluorescence in situ hybridization (FISH), to >100 kb, or the size of a Bacterial Artefact Clone (BAC clone), to <16.4 kb average spatial resolution with oligonucleotide arrays. Especially the higher resolution arrays are able to define the breakpoint of rearrangements and to accurately detect copy number.
Here we present the clinical and molecular findings in a 6-year-old boy with a duplication of about 12.9 Mb that involves the region 15q11.2-q13.3 along with a deletion of approximately 3.2 Mb on the long arm of chromosome 22, at the region 22q11.1-q11.21. The sizes and breakpoints of the deletion and duplication were determined through oligo array-CGH analysis. To our knowledge this is the first case of concurrence of DiGeorge syndrome with a maternally inherited 15q12.2-q13.3 duplication. The aim of this study is to correlate the molecular findings with the proband's clinical phenotype and to demonstrate that molecular cytogenetic techniques used in the parents were necessary for the genetic counseling of the family.
The proband, a 6-year-old boy, is the first child of non-consanguineous, healthy 30 year-old parents. The family history was unremarkable. Pregnancy was uneventful, there was no prenatal exposure to teratogens but the prenatal ultrasound examination showed exadactyly (right hand). Amniocentesis revealed a normal karyotype 46,XY. The proband was born at 35 weeks of gestation by normal delivery, with birth weight of 2600 g, length 49 cm and head circumference 31 cm, all within normal range for the age of gestation. Apgar scores were 9/1" and 10/5" and he had an uncomplicated perinatal period. At birth he presented radial exadactyly and syndactyly of 3rd and 4th fingers (right) as well as a radial ulnar (left) rudimentary supernumerary finger and other malformations. Ultrasound of brain/abdomen and cardiovascular examination were normal.
Radiological re-examination of the right hand at the first year of life showed syndactyly of the 3rd and 4th fingers and a supernumerary dysplastic finger which was surgically removed. Two years later surgical axonal repair of the syndactyly was performed and since then the patient has been regularly followed up by orthopaedists.
His initial motor development was slightly retarded; head control was achieved at the age of 5 months, unsupported sitting at 16 months and walking at 18 months. His language acquisition was also delayed. Early developmental intervention with physiotherapy and sessions for speech improvement showed gradual but not remarkable progress. Audiologic evaluation revealed congenital sensorineural hearing loss bilaterally (80-90 dB) which was not attributed to the 35delG mutation of the connexin 26 gene (GJB2) after molecular analysis by PCR . Fragile-X syndrome was also excluded, while MRI of the brain was within normal limits.
During three hospitalizations at the age of 4 and 5 years due to recurrent right lung pneumonia, extended immunologic studies excluded immunodeficiency. Routine blood and urine biochemical investigations as well as thorough metabolic and endocrinological evaluation showed no abnormality while ophthalmologic evaluation revealed hypermetropy. The examination of internal organs by ultrasonography was also negative for any pathology.
The boy was referred for genetic evaluation at the age of 6 years. He showed growth retardation [height at 105 cm (<3rd centile), weight 17 kg (3rd centile), head circumference 49.5 cm (3rd centile)], made 2-5 word phrases and exhibited learning difficulties. Dysmorphic features included facial weakness, blepharoptosis (not myopathetic type), downslanting palpebral fissures, epicanthus, full cheeks, thick/small/low-set/dysplastic ears, high-arched palate, chin dimpling, bulbous nasal tip, and microstomia.
Chromosome analysis of the proband was performed using GTG-banding techniques on stimulated blood lymphocytes. Cytogenetics revealed a normal karyotype 46,XY (Figure 1).
Due to the clinical findings fluorescence in situ hybridization (FISH) using a probe specific for DiGeorge Syndrome critical region (TUPLE) was performed. A single red signal could be seen on the normal chromosome 22 (Figure 2), while the red signal was absent on the homologous chromosome 22. Two green signals were seen on the subtelomere of both homologues (control probe).
Due to atypical clinical findings molecular karyotyping was performed through array-CGH analysis on the proband's DNA by using an Agilent 60 K array platform. This analysis showed a 22q11.1-q11.21 deletion of about 3.2 Mb, with distal breakpoint falling between 18,691,704 bp (last deleted oligomer) and 19,084,422 bp (first normal oligomer). The first oligomer on the platform for proximal 22q maps at 15,476,855 bp and resulted to be deleted. The analysis also detected a duplication of about 12.9 Mb that involves the 15q11.2-q13.3 region, with distal breakpoint falling between 31,288,255 bp (last duplicated oligomer) and 31,339,610 bp (first normal oligomer). The first oligomer on the platform for proximal 15q maps at 18,362,555 bp and was duplicated (Figure 3).
Parental karyotypes were normal. Parental FISH analysis was requested and the mother was found to carry a cryptic balanced translocation between chromosome 15 and chromosome 22 with a 46,XX,t(15;22)(q11.2;q11.2) karyotype (Figure 4) using the following two probes [TUPLE and TBX1 DiGeorge Region probes (Cytocell)]. The karyotype of the proband was defined as follows: 46,XY,ish der(22)t(15;22)(q11.2;q11.2)(TUPLE-,TBX-)mat.
According to fragment analysis three alleles were observed in the proband using microsatellite markers D15S122, D15S113 and D15S97, all within the PWS/AS critical region. The markers were not informative of the parental origin of the partial trisomy 15. Biparental inheritance of chromosome 15 was observed with marker 85CA.
The long arm of chromosome 15 and essentially the 15q11.2-q14 PWS/AS region is highly susceptible to clinically important genomic rearrangements, including interstitial deletions, duplications, and triplications [17, 18]. Transcriptional regulation of the 15q11-q14 region is highly complex, involving multiple allele-specific epigenetic marks, including DNA methylation, histone modification patterns and DNAse hypersensitive sites . The area also contains a cluster of snoRNA and noncoding RNAs, which are under specific imprinting regulation . Repeat sequences, such as low copy repeats (LCR) are thought to mediate misalignment of the region during meiosis, leading to unequal recombination events .
Duplications reported so far usually share two proximal Breakage Points (BPs) (BP1 and BP2) and usually one distal BP3 and include PWACR. More distal BPs (BP4 and BP5) are involved in large inv-dup(15)s and intrachromosomal triplications [17, 21]. The frequency of 15q11-q13 interstitial duplications is estimated at 1:600 individuals referred with developmental delay .
Interstitial duplications of proximal 15q that do not include the PWS/AS critical region have no clinical effect, are usually familial, and may be considered normal variants . Patients with interstitial duplications of the PWS/AS locus have an abnormal phenotype that includes developmental delay, particularly affecting speech and language; varying degrees of mental retardation; autism or autistic features; motor coordination difficulties; and mild or no dysmorphic features . The phenotype is highly variable, even among members of the same family carrying identical rearrangements  and can in some cases manifest as developmental language disorder and dyspraxia, without autism . Increased dosage of the PWS/AS critical gene region between BP2 and BP3 positively correlates with phenotypic severity in patients with 15q11-q13 duplications, however clinical heterogeneity in patients is not explained by variation in breakpoints only, suggesting that additional factors contribute to clinical complexity. At least 33 cases of interstitial duplications of the 15q11-q13 region have been reported in association with ASDs, according to the Autism Chromosome Rearrangement Database (http://projects.tcag.ca/autism/).
Overexpression of maternally imprinted genes through duplication of chromosome 15q11-q14 also displays parent-of-origin effects, with maternal duplications being associated with a complex neurobehavioral phenotype that often includes autism, cognitive deficits and seizures [10, 11, 4]. Twenty-five cases with maternal origin of the intrachromosomal duplication showed a range of phenotypic features from severe mental retardation, developmental delay, seizures, nonspecific hypotonia, and mild facial anomalies to only developmental delay and autism [16, 24, 26, 27].
One case of autistic disorder associated with a paternally derived unbalanced translocation leading to duplication of chromosome 15pter-q13.2 has been reported, suggesting that biallelically expressed genes on proximal 15q contribute to the autism phenotype .
Regarding the developmental outcome of our proband, he lacked seizures and autistic behavior which have been associated with 15q11-q13 duplication. He had marked psychomotor delay, expressed primarily as poor speech, probably attributed to the 15q11-q13 duplication since 22q11 deletion mostly causes mild retardation [1, 14].
Congenital heart defects, mainly of the cardiac outflow tract and aortic arch, commonly severe, are present in 75% of patients with DiGeoge syndrome and are possibly associated with TBX1 haploinsufficiency . In our proband though, the congenital heart defect was restricted to transient patent foramen ovale which is a simple and non life-threatening anomaly. Within the spectrum of DGS/VCFS, small ears and deafness are listed, but usually the latter is conductive and when sensorineural, as in our patient, is bilateral. Our proband was lacking several of the most common features referred within the clinical spectrum of del22q11.2-q11.21, as immunodeficiency, various endocrinological manifestations and hypocalcemia . The polydactyly (either pre- or postaxial) has also been described, but not syndactyly that the patient also demonstrated. The frequency of inherited 22q11.2 deletions reported by Ryan et al 1997 , is much higher than in previous studies (28% versus 10%, respectively) and it has been suggested that both parents should be investigated in any case of DGS/VCFS [31, 32]. Mosaic cases of 22q11.2 microdeletion syndrome seem very rare .
Another case of a cryptic translocation in one of the healthy parents was reported  in a case where FISH showed a t(1;17)(q44;p13.2) translocation in the father, which subsequently enabled the characterization of the der(1) chromosomal abnormality in the index patient. It is important that cryptic translocations are kept in mind, and that parental karyotypes are analyzed in cases of mentally retarded children with normal karyotype.
Our report adds another case of maternal origin of 15q11-q13 duplication in the current literature and shows again the syndrome variability which becomes more obscure when accompanied by another chromosomal abnormality, as 22q11 deletion. Furthermore, it represents, as far as we know, the first case of concurrence of 22q11.1-q11.21 deletion (mat) with 15q11.2-q13.3 duplication. It illustrates the value of thorough clinical evaluation and multiple genetic tests in patients with unexplained developmental delay and major congenital anomalies as well as in their parents with the scope of excluding possible balanced translocations predisposing to genetic risk. We suggest that reporting of similar well-characterized clinical cases with clearly delineated breakpoints of the duplicated region will clarify the contribution of specific genes to the phenotype and will offer accurate genotype versus phenotype correlation that should allow a more precise prognosis.
Materials and methods
Chromosome analysis and FISH
Chromosome analysis was carried out on PHA-stimulated lymphocytes with standard GTG-banding technique. FISH studies were performed by use of the standard method described by Pinkel et al (1988) . Hybridization signals were detected by two digoxigenin (DIG) - probes according to the manufacturer's instructions. The probes used were DiGeorge and 22q13.3 Deletion Syndrome Probe Combinations (Cytocell). Two out of three commercially available probes from Cytocell were used:
VCFS TUPLE 1 Region deletion probe, labeled in red which measures approximately 120 kb and covers the entire TUPLE1 gene and flanking DNA,
TBX1 Region deletion probe labeled in red, which is approximately 213 kb, and contains the D22S1627 marker. Both are DIG-probes directly labeled with a red fluorochrome (Texas Red spectrum) and accompanied by the 22 telomere control probe directly labeled with a green fluorophore (FITC spectrum).
A total of 40 metaphases from each probe of the proband and a total of 20 metaphases from each probe of the carrier mother were examined after the hybridization and the number and relative position of signals were recorded. Signal distribution and intensity from the normal chromosome 22 homologue acted as an internal control for the efficiency and stringency of the hybridization experiment. Analysis was performed by use of a conventional Zeiss epifluorescent Axioskop 2plus microscope, and images were captured, enhanced and analyzed by use of Cytovision (Applied Imaging) software. Both the conventional cytogenetics and FISH results were described according to the 2009 International System for Human Cytogenetics Nomenclature (ISCN) .
Molecular karyotyping was carried out on DNA extracted from whole blood of the patient and both his parents according to standard procedures. All the experiments were conducted through oligo array-CGH platforms (SurePrint G3 Human CGH Microarray, 8 × 60 K, Agilent Technologies, Santa Clara, CA, USA). Briefly 500 ng of the proband and of a sex-matched reference DNAs (NA10851, Coriell Cell Repositories) were processed according to the manufacturer's protocol. Fluorescence was scanned in a dual-laser scanner (DNA Microarray Scanner with Sure Scan High-Resolution Technology, Model G2565CA, Agilent Technologies, Santa Clara, CA, USA) and the images were extracted and analyzed through Agilent Feature Extraction Software (v10.5.1.1). Graphical overview was obtained using the DNA Analytics software (v4.0.73). Changes in test DNA copy number at a specific locus were observed as the deviation of the log2 ratio value of 0 of at least three consecutive probes. The quality of each experiment was assessed by using a parameter provided by Agilent software (QC metric). Copy number changes identified in the samples were visualized by using the UCSC Genome Browser website (http://genome.ucsc.edu) and also compared to the Database of Genomic Variants (http://projects.tcag.ca/variation) to exclude copy number changes considered as benign variants. The positions of oligomers refer to the Human Genome March 2006 (versions NCBI 36, hg18) assembly. The DECIPHER (https://decipher.sanger.ac.uk/) and ECARUCA (http://agserver01.azn.nl:8080/ecaruca/ecaruca.jsp) databases were expedient as resources to aid genotype-phenotype correlation.
Chromosome 15 microsatellite markers 85CA, D15S122, GABRB3, D15S113, CYP19, D15S97, and FES were genotyped. The DNA fragments were amplified by polymerase chain reaction (PCR) and the products were further diluted in Hi-Di™ formamide and GeneScan™ 500 LIZ® which were used as an internal lane size standard in order to enable automated data analysis and precise DNA fragment size comparisons between electrophoresis runs. The final products were separated by capillary electrophoresis on an ABI 310 genetic analyzer (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's protocol and the results were evaluated using the GeneMapper v4.0 software (Applied Biosystems, Foster City, CA, USA).
Written informed consent was obtained from the parents of the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Scamber PJ: The 22q11 deletion syndromes. Hum Mol Genet 2000, 9: 2421–2426. 10.1093/hmg/9.16.2421
Vantrappen G, Devriendt K, Swillen A, Rommel N, Vogels A, Eyskeus B: Presenting symptoms and clinical features in 130 patients with velo-cardio-facial syndrome. The Leuven experience. Genet Couns 1999, 10: 3–9.
Devriendt K, Fryns JP, Mortier G, van Thienen MN, Keymolen K: The annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet 1998, 35: 789–790. 10.1136/jmg.35.9.789-a
Hogart A, Leung KN, Wang NJ, Wu DJ, Driscoll J, Vallero RO, Schanen NC, LaSalle JM: Chromosome 15q11–13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number. J Med Genet 2009, 46: 86–93. 10.1136/jmg.2008.061580
Orrico A, Galli L, Grosso S, Buoni S, Pianigiani R, Balestri P, Sorrentino V: Mutational analysis of the SCN1A, SCN1B and GABRG2 genes in 150 Italian patients with idiopathic childhood epilepsies. Clin Genet 2009, 75: 579–581. 10.1111/j.1399-0004.2008.01074.x
Cook EH Jr, Lindgren V, Leventhal BL, Courchesne R, Lincoln A, Shulman C, Lord C, Courchesne E: Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet 1997, 60: 928–934.
Lord C, Cook EH, Leventhal BL, Amaral DG: Autism spectrum disorders. Neuron 2000, 28: 355–363. 10.1016/S0896-6273(00)00115-X
Schroer RJ, Phelan MC, Michaelis RC, Crawford EC, Skinner SA, Cuccaro M, Simensen RJ, Bishop J, Skinner C, Fender D, Stevenson RE: Autism and maternally derived aberrations of chromosome 15q. Am J Med Genet 1998, 76: 327–336. 10.1002/(SICI)1096-8628(19980401)76:4<327::AID-AJMG8>3.0.CO;2-M
Dawson G, Munson J, Estes A, Osterling J, McPartland J, Toth K, Carver L, Abbott R: Neurocognitive function and joint attention ability in young children with autism spectrum disorder versus developmental delay. Child Dev 2002, 73: 345–358. 10.1111/1467-8624.00411
Wang NJ, Liu D, Parokonny AS, Schanen NC: High-resolution molecular characterization of 15q11-q13 rearrangements by array comparative genomic hybridization (array CGH) with detection of gene dosage. Am J Hum Genet 2004, 75: 267–281. 10.1086/422854
Vorstman JA, Staal WG, van Daalen E, van Engeland H, Hochstenbach PF, Franke L: Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol Psychiatry 2006, 11: 1–18. 28 10.1038/sj.mp.4001781
Clayton-Smith J, Webb T, Cheng XJ, Pembrey ME, Malcolm S: Duplication of chromosome 15 in the region 15q11–13 in a patient with developmental delay and ataxia with similarities to Angelman syndrome. J Med Genet 1993, 30: 529–531. 10.1136/jmg.30.6.529
Bundey S, Hardy C, Vickers S, Kilpatrick MW, Corbett JA: Duplication of the 15q11–13 region in a patient with autism, epilepsy and ataxia. Dev Med Child Neurol 1994, 36: 736–742. 10.1111/j.1469-8749.1994.tb11916.x
Kitsiou-Tzeli S, Tzetis M, Sofocleous C, Vrettou C, Xaidara A, Giannikou K, Pampanos A, Mavrou A, Kanavakis E: De novo interstitial duplication of the 15q11.2-q14 PWS/AS region of maternal origin: clinical description, array CGH analysis, and review of the literature. Am J Med Genet 2010, 152: 1925–1932. 10.1002/ajmg.a.33447
Szafranski P, Schaaf CP, Person RE, Gibson IB, Xia Z, Mahadevan S, Wiszniewska J, Bacino CA, Lalani S, Potocki L, Kang SH, Patel A, Cheung SW, Probst FJ, Graham BH, Shinawi M, Beaudet AL, Stankiewicz P: Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological? Hum Mutat 2010, 31: 840–850. 10.1002/humu.21284
Pampanos A, Economides J, Iliadou V, Neou P, Leotsakos P, Voyiatzis N, Eleftheriades N, Tsakanikos M, Antoniadi T, Hatzaki A, Konstantopoulou I, Yannoukakos D, Gronskov K, Brondum-Nielsen K, Grigoriadou M, Gyftodimou J, Iliades T, Skevas A, Petersen MB: Prevalence of GJB2 mutations in prelingual deafness in the Greek population. Int J Pediatr Otorhinolaryngol 2002, 65: 101–108. 10.1016/S0165-5876(02)00177-5
Ungaro P, Christian SL, Fantes JA, Mutirangura A, Black S, Reynolds J, Malcolm S, Dobyns WB, Ledbetter DH: Molecular characterisation of four cases of intrachromosomal triplication of chromosome 15q11-q14. J Med Genet 2001, 38: 26–34. 10.1136/jmg.38.1.26
Horsthemke B, Wagstaff J: Mechanisms of imprinting of the Prader-Willi/Angelman region. Am J Med Genet A 2008, 146A: 2041–52. 10.1002/ajmg.a.32364
Makoff AJ, Flomen RH: Detailed analysis of 15q11-q14 sequence corrects errors and gaps in the public access sequence to fully reveal large segmental duplications at breakpoints for Prader-Willi, Angelman, and inv dup(15) syndromes. Genome Biol 2007, 8: R114. 10.1186/gb-2007-8-6-r114
Leung KN, Vallero RO, DuBose AJ, Resnick JL, LaSalle JM: Imprinting regulates mammalian snoRNA-encoding chromatin decondensation and neuronal nucleolar size. Hum Mol Genet 2009, 18: 4227–4238. 10.1093/hmg/ddp373
Vialard F, Mignon-Ravix C, Parain D, Depetris D, Portnoï MF, Moirot H, Mattei MG: Mechanism of intrachromosomal triplications 15q11-q13: a new clinical report. Am J Med Genet A 2003, 118A: 229–234. 10.1002/ajmg.a.10164
Thomas JA, Johnson J, Peterson Kraai TL, Wilson R, Tartaglia N, LeRoux J, Beischel L, McGavran L, Hagerman RJ: Genetic and clinical characterization of patients with an interstitial duplication 15q11-q13, emphasizing behavioral phenotype and response to treatment. Am J Med Genet A 2003, 119: 111–120. 10.1002/ajmg.a.10176
Browne CE, Dennis NR, Maher E, Long FL, Nicholson JC, Sillibourne J, Barber JC: Inherited interstitial duplications of proximal 15q: Genotypephenotype correlations. Am J Hum Genet 1997, 61: 1342–1352. 10.1086/301624
Bolton PF, Dennis NR, Browne CE, Thomas NS, Veltman MW, Thompson RJ, Jacobs P: The phenotypic manifestations of interstitial duplications of proximal 15q with special reference to the autistic spectrum disorders. Am J Med Genet 2001, 105: 675–685. 10.1002/ajmg.1551
Boyar FZ, Whitney MM, Lossie AC, Gray BA, Keller KL, Stalker HJ, Zori RT, Geffken G, Mutch J, Edge PJ, Voeller KS, Williams CA, Driscoll DJ: A family with a grand-maternally derived interstitial duplication of proximal 15q. Clin Genet 2001, 60: 421–430. 10.1034/j.1399-0004.2001.600604.x
Cai G, Edelmann L, Goldsmith JE, Cohen N, Nakamine A, Reichert JG, Hoffman EJ, Zurawiecki DM, Silverman JM, Hollander E, Soorya L, Anagnostou E, Betancur C, Buxbaum JD: Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMT. BMC Med Genomics 2008, 1: 50. 10.1186/1755-8794-1-50
Depienne C, Moreno-De-Luca D, Heron D, Bouteiller D, Gennetier A, Delorme R, Chaste P, Siffroi JP, Chantot-Bastaraud S, Benyahia B, Trouillard O, Nygren G, Kopp S, Johansson M, Rastam M, Burglen L, Leguern E, Verloes A, Leboyer M, Brice A, Gillberg C, Betancur C: Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 Region in Autism Spectrum Disorders. Biol Psychiatry 2009, 66: 349–359. 10.1016/j.biopsych.2009.01.025
Wu DJ, Wang NJ, Driscoll J, Dorrani N, Liu D, Sigman M, Schanen NC: Autistic disorder associated with a paternally derived unbalanced translocation leading to duplication of chromosome 15pter-q13.2: a case report. Mol Cytogenet 2009, 2: 27. 10.1186/1755-8166-2-27
Yamagishi H, Srivastava D: Unraveling the genetic and developmental mysteries of 22q11 deletion syndrome. TRENDs in the Molecular Medicine 2003, 9: 383–389. 10.1016/S1471-4914(03)00141-2
Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H, Schuffenhauer S, Oechsler H, Belohradsky B, Prieur M, Aurias A, Raymond FL, Clayton-Smith J, Hatchwell E, McKeown C, Beemer FA, Dallapiccola B, Novelli G, Hurst JA, Ignatius J, Green AJ, Winter RM, Brueton L, Brøndum-Nielsen K, Scambler PJ, et al.: Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997, 34: 789–804. 10.1136/jmg.34.10.798
Swillen A, Vogels A, Devrient J, Fiys JP: Chromosome 22q11 deletion syndrome: update and review at the clinical features, cognitive-behavioral spectrum and psychiatric complications. Am J Med Genet 2000, 97: 128–135. 10.1002/1096-8628(200022)97:2<128::AID-AJMG4>3.0.CO;2-Z
Sullivan KE: Di George syndrome (22q11.2 deletion syndrome). Curr Allergy Asthma Rep 2001, 195: 438–444. 10.1007/s11882-001-0029-z
Halder A, Jain M, Kabra M, Gupta N: Mosaic 22q11.2 microdeletion syndrome: diagnosis and clinical manifestations of two cases. Mol Cytogenet 2008, 1: 18. 10.1186/1755-8166-1-18
Liehr T, Heller A, Eichhorn KH, Beensen V, Schulze E, Starke H, Claussen U, Schreyer I: Inherited cryptic chromosomal aberrations may be more easily detected in their balanced forms: a case report with hidden der(1)t(1;17)(q44;p13.2). Prenat Diagn 2004, 24: 1022–1024. 10.1002/pd.971
Pinkel D, Straume T, Graw JW: Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 1986, 83: 2934–2938. 10.1073/pnas.83.9.2934
Shaffer LG, Slovac ML, Campbell LG: An International System for Human Cytogenetic Nomenclature (2009). S.Karger, Basel; 2009.
The authors declare that they have no competing interests.
EM wrote the manuscript; SKT, EL and AA coordinated the clinical analysis of the patient; EM, CS and KM performed the cytogenetic analysis; AV and KK signed out the molecular cytogenetic results; HK, CS and AP were responsible for the molecular analysis; GK performed the ophthalmologic examination; MBP and SKT coordinated the study. All authors have read and approved the manuscript.
About this article
Cite this article
Manolakos, E., Sarri, C., Vetro, A. et al. Combined 22q11.1-q11.21 deletion with 15q11.2-q13.3 duplication identified by array-CGH in a 6 years old boy. Mol Cytogenet 4, 6 (2011). https://doi.org/10.1186/1755-8166-4-6
- Autism Spectrum Disorder
- Prader Willi Syndrome
- Molecular Karyotyping
- Molecular Cytogenetic Technique